[Retracted] Analysis of the Correlation of Basic Fibroblast Growth Factor in Serum of Patients with Diffuse Large B-Cell Lymphoma with Clinicopathological Efficacy and International Prognostic Index

Table 1

Comparison of serum bFGF levels between the DLBCL group and the healthy control group before treatment (ng/mL,  ± s).

Group	The number of cases	Serum bFGF
A group of patients with DLBCL	115	26.17 ± 2.86
Healthy control group	65	17.25 ± 1.72
t	—	20.897
	—	＜0.001